As per a recent market analysis by Future Market Insights (FMI), the demand in the Protein A Resins Market is anticipated to increase at 8.1% CAGR, surpassing US$ 1.2 Bn by 2031-end.
Download a Sample Copy of report to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1720
Researches conducted on monoclonal antibodies and development of biosimilar drugs will drive the demand for protein A resins. Need for advanced and accurate biosimilars to reduce the risk of cancer across the globe is encouraging research on monoclonal antibodies.
As per FMI, demand for protein A resins is increasing in contract manufacturing organizations (CMO). Favorable research initiatives and funding in CMOs for the manufacturing of monoclonal antibodies will provide impetus to the growth in the market.
The outbreak of COVID-19 accelerated the sales of protein A resins as development of monoclonal antibodies for the treatment of virus increased. Apart from this, demand for natural protein A resins in the purification of monoclonal antibodies burgeoned during the FQ-20.
As natural protein A resins help in minimizing ligand leaching and provide stability to traditional protein A resins, key players are increasing the adoption to for advanced research purposes. On the back of this, demand for natural protein A resins is expected to surge in biopharmaceutical manufacturing companies over the forecast period.
As per FMI, sales of protein A resins for antibody purification will account for maximum share during the forecast period. Rising cases of cancer and other chronic diseases have increased the need for developing monoclonal antibodies for therapeutic uses.
Hence, biopharmaceutical manufacturing companies are actively seeking strategic partnerships and mergers with other key players to launch new products, therapeutic drugs, and gain competitive edge in the industry.
“Steered by increasing demand for biosimilar and monoclonal antibodies for therapeutic use, biopharmaceutical manufacturing companies are increasing investments in research and development activities to push biologics production. This is expected to create lucrative growth opportunities for market players,” says an FMI analyst.
Ask from the Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1720
Key Takeaways:
- The U.S. is expected to dominate the North America’s protein A resins market, holding over 93.5% market share
- The U.K. will account for nearly 24.1% of market share across Europe due to increasing number of biopharmaceutical companies focusing on development of biosimilar drugs
- China is expected to register growth at 9.8% CAGR in East Asia owing to the increasing use of biomaterials in drug research
- Sales of protein A resins across Japan are expected to increase at 7.8% CAGR during the forecast period
- Based on matrix type, agarose based matrix of protein A resins will account for over 85.8% market share in 2021
- Biopharmaceutical manufacturers are expected to be the primary end-users, accounting for 79.2% market share in 2021
Prominent Drivers:
- Growing demand for therapeutic antibodies and extensive research on monoclonal antibodies will boost the market
- Increasing prevalence of cancer has encouraged medical professionals for extensive research on the production of monoclonal antibodies for therapeutic use. This is propelling the demand in the market
Key Restraints:
- High cost of resins and lack of skilled research analysts are expected to restrict the growth in protein A resins market
Request for Customized Report – https://www.futuremarketinsights.com/customization-available/rep-gb-1720
Competitive Landscape
Key players are collaborating with end users and other regional players to strengthen their global presence. Some of the market players are focusing on product launches to capitalize on growing demand for monoclonal antibodies from biopharmaceutical companies. For instance:
- In Spetember 2021, Purolite, a global manufacturer of resin-based chromatography separation, purification, and extraction technologies, announced the commercialization of two novel next-generation chromatography resins.
- In March 2020, Avantor Inc., global provider of mission-critical products and services to customers in the life-sciences, announced a new recombinant Protein A affinity chromatography resin, PROchievA, used to purify antibodies during mAbs production.
Leading players operating in protein A resins market profiled by FMI include:
- GE Healthcare
- Thermo Fisher Scientific
- Kaneka Corporation,
- JNC Corporation
- Purolite Life Sciences
- Bio-Rad Laboratories, Inc.
- JSR Corporation (JSR Life Sciences LLC)
- Repligen
- Tosoh Bioscience, Merck Group (Merck Millipore)
- Novasep Holdings SAS, Agilent Technologies, Inc.
- GenScript, Abcam PLC (Expedeon Ltd.)
- Avantor Inc.
- Takara Bio, PerkinElmer, Inc.
- Suzhou Nanomicro Technology Co., Ltd
- Others
More Insights on FMI’s Protein A Resins Market
The latest market study on the protein A resins market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to offer a better perspective of the global protein A resins market, its growth trajectory, trends, and opportunities, the market is segmented on the basis of:
By Product:
- Natural Protein A Resin
- Recombinant Protein A Resin
By Matrix:
- Agarose Based Matrix
- Glass or Silica Based Matrix
- Organic Polymer Based Matrix
By Application:
- Immunoprecipitation
- Antibody Purification
By End-User:
- Biopharmaceutical Manufacturers
- Clinical Research Laboratories
- Academic Institutes
Explore Other Reports Links from Healthcare Market
Cosmetic Implants Market:- Global Cosmetic Implants Market is estimated to garner US$ 17.9 Billion while exhibiting a 5.8% CAGR during the forecast period. The growing support from several governments is likely to fuel the market growth in the coming years.
Electrosurgery Devices Market:- As per the study at FMI, the Electrosurgery Devices Market is valued at US$ 3.3 Billion in 2022 and is expected to reach US$ 5.1 billion by 2032.
Disposable Blood Pressure Cuffs Market:- The Disposable Blood Pressure Cuffs Market is likely to amass a revue of around US$ 783.0 million in 2032, up from US$ 244.7 million in 2022, moving ahead with a CAGR of 12.3% during the forecast period (2022-2032).
Antidiabetics Market:- The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market’s expansion.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs